Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis
- Autores
- Elgoyhen, Ana Belen; Langguth, B.; Nowak, Wanda; Schecklmann, M.; de Ridder, D.; Vanneste, S.
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Tinnitus, phantom sound perception, is a worldwide highly prevalent disorder for which no clear underlying pathology has been established and for which no approved drug is on the market. Thus, there is an urgent need for new approaches to understand this condition. We used a network pharmacology side-effect analysis to search for genes that are involved in tinnitus generation. We analyzed a network of 1,313 drug–target pairs, based on 275 compounds that elicit tinnitus as side effect and their targets reported in databases, and used a quantitative score to identify emergent significant targets that were more common than expected at random. Cyclooxigenase 1 and 2 were significant, which validates our approach, since salicylate is a known tinnitus generator. More importantly, we predict previously unknown tinnitus-related targets. The present results have important implications toward understanding tinnitus pathophysiology and might pave the way toward the design of novel pharmacotherapies.
Fil: Elgoyhen, Ana Belen. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; Argentina
Fil: Langguth, B.. University of Regensburg. Interdisciplinary Tinnitus Clinic. Department of Psychiatry and Psychotherapy; Alemania
Fil: Nowak, Wanda. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; Argentina
Fil: Schecklmann, M.. University of Regensburg. Interdisciplinary Tinnitus Clinic. Department of Psychiatry and Psychotherapy; Alemania
Fil: de Ridder, D.. University of Otago. Dunedin School of Medicine. Unit of Neurosurgery. Department of Surgical Sciences; Nueva Zelanda
Fil: Vanneste, S.. University of Texas at Dallas. School of Behavioral and Brain Sciences. Laboratory for Auditory & Integrative Neuroscience; Estados Unidos - Materia
-
Tinnitus
Network pharmacology - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/4010
Ver los metadatos del registro completo
id |
CONICETDig_698696d1f7b4c584c5ee1f27fc55024e |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/4010 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network AnalysisElgoyhen, Ana BelenLangguth, B.Nowak, WandaSchecklmann, M.de Ridder, D.Vanneste, S.TinnitusNetwork pharmacologyhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Tinnitus, phantom sound perception, is a worldwide highly prevalent disorder for which no clear underlying pathology has been established and for which no approved drug is on the market. Thus, there is an urgent need for new approaches to understand this condition. We used a network pharmacology side-effect analysis to search for genes that are involved in tinnitus generation. We analyzed a network of 1,313 drug–target pairs, based on 275 compounds that elicit tinnitus as side effect and their targets reported in databases, and used a quantitative score to identify emergent significant targets that were more common than expected at random. Cyclooxigenase 1 and 2 were significant, which validates our approach, since salicylate is a known tinnitus generator. More importantly, we predict previously unknown tinnitus-related targets. The present results have important implications toward understanding tinnitus pathophysiology and might pave the way toward the design of novel pharmacotherapies.Fil: Elgoyhen, Ana Belen. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; ArgentinaFil: Langguth, B.. University of Regensburg. Interdisciplinary Tinnitus Clinic. Department of Psychiatry and Psychotherapy; AlemaniaFil: Nowak, Wanda. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; ArgentinaFil: Schecklmann, M.. University of Regensburg. Interdisciplinary Tinnitus Clinic. Department of Psychiatry and Psychotherapy; AlemaniaFil: de Ridder, D.. University of Otago. Dunedin School of Medicine. Unit of Neurosurgery. Department of Surgical Sciences; Nueva ZelandaFil: Vanneste, S.. University of Texas at Dallas. School of Behavioral and Brain Sciences. Laboratory for Auditory & Integrative Neuroscience; Estados UnidosWiley2014-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/4010Elgoyhen, Ana Belen; Langguth, B.; Nowak, Wanda; Schecklmann, M.; de Ridder, D.; et al.; Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis; Wiley; CPT: Pharmacometrics & Systems Pharmacology; 3; 1; 1-2014; 1-102163-8306enginfo:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1038/psp.2013.75/abstract;jsessionid=9E3152C54341E5E91E35D696B032DFF9.f04t02info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910011/info:eu-repo/semantics/altIdentifier/doi/10.1038%2Fpsp.2013.75info:eu-repo/semantics/altIdentifier/issn/2163-8306info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:56:14Zoai:ri.conicet.gov.ar:11336/4010instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:56:14.839CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis |
title |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis |
spellingShingle |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis Elgoyhen, Ana Belen Tinnitus Network pharmacology |
title_short |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis |
title_full |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis |
title_fullStr |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis |
title_full_unstemmed |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis |
title_sort |
Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis |
dc.creator.none.fl_str_mv |
Elgoyhen, Ana Belen Langguth, B. Nowak, Wanda Schecklmann, M. de Ridder, D. Vanneste, S. |
author |
Elgoyhen, Ana Belen |
author_facet |
Elgoyhen, Ana Belen Langguth, B. Nowak, Wanda Schecklmann, M. de Ridder, D. Vanneste, S. |
author_role |
author |
author2 |
Langguth, B. Nowak, Wanda Schecklmann, M. de Ridder, D. Vanneste, S. |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
Tinnitus Network pharmacology |
topic |
Tinnitus Network pharmacology |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Tinnitus, phantom sound perception, is a worldwide highly prevalent disorder for which no clear underlying pathology has been established and for which no approved drug is on the market. Thus, there is an urgent need for new approaches to understand this condition. We used a network pharmacology side-effect analysis to search for genes that are involved in tinnitus generation. We analyzed a network of 1,313 drug–target pairs, based on 275 compounds that elicit tinnitus as side effect and their targets reported in databases, and used a quantitative score to identify emergent significant targets that were more common than expected at random. Cyclooxigenase 1 and 2 were significant, which validates our approach, since salicylate is a known tinnitus generator. More importantly, we predict previously unknown tinnitus-related targets. The present results have important implications toward understanding tinnitus pathophysiology and might pave the way toward the design of novel pharmacotherapies. Fil: Elgoyhen, Ana Belen. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; Argentina Fil: Langguth, B.. University of Regensburg. Interdisciplinary Tinnitus Clinic. Department of Psychiatry and Psychotherapy; Alemania Fil: Nowak, Wanda. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; Argentina Fil: Schecklmann, M.. University of Regensburg. Interdisciplinary Tinnitus Clinic. Department of Psychiatry and Psychotherapy; Alemania Fil: de Ridder, D.. University of Otago. Dunedin School of Medicine. Unit of Neurosurgery. Department of Surgical Sciences; Nueva Zelanda Fil: Vanneste, S.. University of Texas at Dallas. School of Behavioral and Brain Sciences. Laboratory for Auditory & Integrative Neuroscience; Estados Unidos |
description |
Tinnitus, phantom sound perception, is a worldwide highly prevalent disorder for which no clear underlying pathology has been established and for which no approved drug is on the market. Thus, there is an urgent need for new approaches to understand this condition. We used a network pharmacology side-effect analysis to search for genes that are involved in tinnitus generation. We analyzed a network of 1,313 drug–target pairs, based on 275 compounds that elicit tinnitus as side effect and their targets reported in databases, and used a quantitative score to identify emergent significant targets that were more common than expected at random. Cyclooxigenase 1 and 2 were significant, which validates our approach, since salicylate is a known tinnitus generator. More importantly, we predict previously unknown tinnitus-related targets. The present results have important implications toward understanding tinnitus pathophysiology and might pave the way toward the design of novel pharmacotherapies. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/4010 Elgoyhen, Ana Belen; Langguth, B.; Nowak, Wanda; Schecklmann, M.; de Ridder, D.; et al.; Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis; Wiley; CPT: Pharmacometrics & Systems Pharmacology; 3; 1; 1-2014; 1-10 2163-8306 |
url |
http://hdl.handle.net/11336/4010 |
identifier_str_mv |
Elgoyhen, Ana Belen; Langguth, B.; Nowak, Wanda; Schecklmann, M.; de Ridder, D.; et al.; Identifying Tinnitus-Related Genes Based on a Side-Effect Network Analysis; Wiley; CPT: Pharmacometrics & Systems Pharmacology; 3; 1; 1-2014; 1-10 2163-8306 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1038/psp.2013.75/abstract;jsessionid=9E3152C54341E5E91E35D696B032DFF9.f04t02 info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910011/ info:eu-repo/semantics/altIdentifier/doi/10.1038%2Fpsp.2013.75 info:eu-repo/semantics/altIdentifier/issn/2163-8306 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley |
publisher.none.fl_str_mv |
Wiley |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269393447288832 |
score |
13.13397 |